Galderma Laboratories L.Pal Revenue and Competitors
Estimated Revenue & Valuation
- Galderma Laboratories L.Pal's estimated annual revenue is currently $62.5M per year. 0
Employee Data
- 00
Galderma Laboratories L.Pal's People
Name | Title | Email/Phone |
---|
Galderma Laboratories L.Pal Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $26.7M | 133 | 20% | N/A | N/A |
#2 | $13.5M | 67 | 6% | N/A | N/A |
#3 | $16.1M | 80 | -2% | N/A | N/A |
#4 | $62.5M | 0 | N/A | N/A | N/A |
#5 | $10.1M | 50 | 6% | N/A | N/A |
#6 | $119.4M | 594 | 27% | N/A | N/A |
#7 | $22.9M | 114 | 8% | N/A | N/A |
#8 | $92.9M | 462 | 8% | N/A | N/A |
#9 | $11.3M | 56 | -8% | N/A | N/A |
#10 | $7M | 35 | 6% | N/A | N/A |
What Is Galderma Laboratories L.Pal?
CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company currently focused on providing innovative medical therapies to the dental and dermatology markets. The Company's lead product, Periostat, was approved by the FDA in September 1998 and is the first and only pharmaceutical to treat periodontal disease by inhibiting the enzymes that destroy periodontal support tissues.
keywords:N/AN/A
Total Funding
N/A
Number of Employees
$62.5M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Galderma Laboratories L.Pal News
2022-04-06 - Skincare Market Is Projected to Grow at A Robust CAGR of 8.1 ...
For instance, in 2021, Galderma Laboratories, L.P.-Cetaphil ... L.P., PDI, Inc., Betco Corporation, Pal International, PSK Pharma Pvt. Ltd.,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 1 | 0% | N/A |
#2 | $0.1M | 1 | 0% | N/A |
#3 | N/A | 1 | 0% | N/A |
#4 | $0.1M | 1 | -50% | N/A |
#5 | N/A | 1 | 0% | N/A |